Back to companies

Boehringer Ingelheim International GmbH: Overview

Boehringer Ingelheim International GmbH (Boehringer), a subsidiary of CH Boehringer Sohn AG & Co KG, is a pharmaceutical company that develops, manufactures and markets of pharmaceuticals, parasiticides, vaccines and therapeutics for unmet medical needs. It offers a wide range of products including human diseases, animal health care products and biopharmaceuticals. The company’s products are used for the treatment central nervous system disorders, cardiometabolic diseases, respiratory diseases, cancer, immunology and retinal diseases among others. It also offers animal healthcare products for Swine, Ruminant, Poultry, Horses, Pets etc. It operates facilities for manufacture pharmaceuticals and medical products. Boehringer is headquartered in Ingelheim am Rhein, Rheinland-Pfalz, Germany.

Headquarters Germany

Address Binger Strasse 173, Ingelheim am Rhein, Rheinland-Pfalz, 55216


Telephone 49 6132 770

No of Employees 51,944

Industry Pharmaceuticals and Healthcare

Revenue (2021) $24.4B

   

   

Access premium data and analytics for Boehringer Ingelheim International GmbH

2,400+

Clinical Trials

Determine Boehringer Ingelheim International GmbH go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

640+

Catalyst Calendar

Proactively evaluate Boehringer Ingelheim International GmbH’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

630+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Boehringer Ingelheim International GmbH’s relevant decision makers and contact details.

350+

Pipeline Drugs

Identify which of Boehringer Ingelheim International GmbH’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

160+

Marketed Drugs

Understand Boehringer Ingelheim International GmbH’s commercialized product portfolio to stay one step ahead of the market.

140+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

50+

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

20+

Sales & Consensus Forecasts

Understand the current and future drug revenue for Boehringer Ingelheim International GmbH and assess market opportunity for new entrants with patient population 8-year forecasts.

4

Investigators

Review investigator profiles and find information on trial contacts across Boehringer Ingelheim International GmbH, including performance indicators like number of completed trials, and linked attributes such as rehiring statistics.

420+

Consumer Market Data Insights

Insight into market share and brand performance.

370+

Install Base

Install Base provides the user with a holistic as well as granular level view of the product deployments of leading vendors across geographies and sectors. Using the tool users can also get an understanding of various vendors’ products or solutions deployed by a prospect.

90+

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

11+

Medical Marketed Products

A database of medical devices currently for sale around the world. Devices that have been approved by a regulatory authority are included.

7

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

Subscribe to Company Analytics & gain access to premium industry data & analytics Subscribe to Company Analytics & gain access to premium industry data & analytics Start Here

Products and Services

Products Services Brands
Human Pharmaceuticals: Contract Manufacturing Spiriva
Prescription Medicine Spiriva Handihaler
Cardiometabolic Diseases Spiriva Respimat
XXX XXX
XXX XXX
XXX XXX
Subscribe to Company Analytics for access to more products & services data Subscribe to Company Analytics for access to more products & services data Learn More

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2022 Contracts/Agreements In June, the company agreed to acquire Trutino Biosciences, a pre-clinical stage biotech company.
2022 New Products/Services In April, the company launched RenuTend, a new stem cell therapy to improve the healing of tendon and suspensory ligament injuries in horses.
2022 Contracts/Agreements In April, the company entered into an early discovery research collaboration with VantAI to identify novel protein degraders.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Get Started
Image for loader

Competitor Comparison

Key Parameters Boehringer Ingelheim International GmbH Pfizer Inc F. Hoffmann-La Roche Ltd Novartis AG Bristol-Myers Squibb Co
Headquarters Germany United States of America Switzerland Switzerland United States of America
City Ingelheim am Rhein New York Basel Basel New York
State/Province Rheinland-Pfalz New York - - New York
No. of Employees 51,944 79,000 100,920 108,000 32,200
Entity Type Private Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Executives
Name Position Board Since Age
Hubertus von Baumbach Chairman Executive Board - -
Carinne Knoche-Brouillon Director - Human Pharma Business Unit Senior Management 2020 55
Matthias Reinig Head - Group Communications Senior Management - -
Jean Scheftsik de Szolnok Director - Animal Health Business Unit Senior Management 2020 57
Michael Schmelmer Director - Finance & Group Functions Senior Management 2019 56
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Gain more insight into company management & employee structure with Company Analytics Gain more insight into company management & employee structure with Company Analytics Subscribe
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer